Reed’s Receives NYSE Deficiency Notification Regarding Stockholders’ Equity
Reed’s (NYSE American: REED) received a NYSE American deficiency notice dated May 29, 2026.
Rhea-AI Summary
Reed’s (NYSE American: REED) received a NYSE American deficiency notice dated May 29, 2026. The exchange found the company below Sections 1003(a)(ii) and (iii) because stockholders’ equity was $2.7 million on March 31, 2026 and it recorded net losses in its five most recent fiscal years.
Reed’s is not eligible for an equity exemption and must submit a compliance plan by June 28, 2026, outlining how it will meet continued listing standards by November 29, 2027. During the 18‑month cure period, REED shares remain listed, subject to compliance with other NYSE American rules.
Positive
- 18‑month cure period to work toward NYSE American compliance
- Common stock continues trading on NYSE American during cure period
Negative
- Stockholders’ equity reported at $2.7 million on March 31, 2026
- Net losses in each of the last five fiscal years
- Non‑compliance with NYSE American Sections 1003(a)(ii) and (iii)
- Not eligible for exemptions from stockholders’ equity requirements
- Must regain compliance with continued listing standards by November 29, 2027
Details
News Market Reaction – REED
In the Jun 4 session, REED declined 6.32%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Stockholders’ equity
- $2.7 million
- As of March 31, 2026 per NYSE American notice
- Net loss duration
- 5 fiscal years
- Net losses in five most recent fiscal years
- Plan submission deadline
- June 28, 2026
- Date by which compliance plan must be submitted
- Compliance deadline
- November 29, 2027
- Target date to regain NYSE American compliance
- Cure period length
- 18 months
- NYSE American cure period for equity deficiency
Historical Context
-
Weaker Q1 sales, sharply lower margins, and widened net loss.
-
Announcement of timing and access details for Q1 2026 call.
-
New COO named to drive manufacturing and operational efficiencies.
-
FY 2025 sales decline, margin compression, and wider net loss with leadership change.
-
Scheduling of Q4 and full-year 2025 results conference call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
stockholders’ equity financial
listing standards regulatory
stockholders’ equity requirements regulatory
continued listing standards regulatory
cure period regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
NORWALK, Conn., June 03, 2026 (GLOBE NEWSWIRE) -- Reed’s, Inc. (NYSE American: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, announced that on May 29, 2026, the Company received a notice (the “Notice”) from NYSE American LLC (“NYSE American”) that the Company is below compliance with Sections 1003(a)(ii) and (iii) of NYSE American’s listing standards set forth in Part 10 of the NYSE American Company Guide (the “Company Guide”) because the Company reported stockholders’ equity of
In connection with its non-compliance with Sections 1003(a)(ii) and (iii) of the Company Guide, the Company must submit a plan by June 28, 2026, advising of actions it has taken or will take to regain compliance with the continued listing standards by November 29, 2027. During the eighteen-month cure period, the Company’s common stock will continue to be listed and traded on NYSE American, subject to the Company’s continued compliance with the NYSE American’s other applicable listing rules.
About Reed’s, Inc.
Reed’s is an innovative company and category leader that provides the world with high quality, premium and better-for-you sodas. Established in 1989, Reed's is a leader in craft beverages under the Reed’s®, Virgil’s® and Flying Cauldron® brand names. The Company’s beverages are now sold in over 32,000 stores nationwide.
Forward Looking Statements
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not historical are forward-looking statements. These forward-looking statements may be identified by terms such as ““believe,”“ “expect,” “intends,” “outlook,” “may,” “will” and similar expressions. Forward-looking statements include, but are not limited to, statements herein with respect to implied or express statements regarding the Company’s expectations surrounding the submission of a plan and regaining compliance with the NYSE American’s continued listing standards, and actions of the Company and/or the NYSE American to be taken with respect to matters discussed in the Notice. These forward-looking statements are based on current expectations. The achievement or success of the matters covered by such forward-looking statements involves risks, uncertainties, and assumptions, many of which involve factors or circumstances that are beyond our control. These risks could cause actual results to differ materially from those discussed in such forward-looking statements.
The risks and uncertainties referred to above include, but are not limited to: Reed’s ability to timely submit its plan to NYSE American, the acceptance of its plan by NYSE American and Reed’s ability to regain compliance with the listing standards set forth in the Company Guide by November 29, 2027, and other risks detailed from time to time in Reed’s public filings, including Reed’s annual report on Form 10-K filed on March 25, 2026, which will be available on the Securities and Exchange Commission’s web site at www.sec.gov. These forward-looking statements are based on current expectations and speak only as of the date hereof. Reed’s assumes no obligation and does not intend to update these forward-looking statements, except as required by law.
Investor Relations Contact
Sean Mansouri, CFA or Aaron D’Souza
Elevate IR
ir@reedsinc.com
(720) 330-2829
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.